Asahi Life Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,345
Closed -$321K 164
2025
Q1
$321K Buy
2,345
+60
+3% +$8.58K 0.21% 135
2024
Q4
$349K Buy
2,285
+485
+27% +$81.8K 0.21% 112
2024
Q3
$349K Buy
+1,800
New +$377K 0.21% 133
2024
Q2
Sell
-1,660
Closed -$358K 155
2024
Q1
$358K Buy
+1,660
New +$389K 0.21% 117
2023
Q2
Sell
-1,310
Closed -$364K 191
2023
Q1
$364K Sell
1,310
-15
-1% -$4.15K 0.12% 105
2022
Q4
$367K Sell
1,325
-515
-28% -$145K 0.12% 103
2022
Q3
$491K Buy
1,840
+10
+0.5% +$2.12K 0.15% 64
2022
Q2
$373K Buy
+1,830
New +$374K 0.1% 82
2021
Q1
Sell
-2,140
Closed -$524K 199
2020
Q4
$524K Buy
2,140
+300
+16% +$77.4K 0.07% 103
2020
Q3
$522K Buy
1,840
+790
+75% +$220K 0.08% 70
2020
Q2
$281K Buy
+1,050
New +$316K 0.05% 135
2020
Q1
Sell
-1,840
Closed -$546K 195
2019
Q4
$546K Sell
1,840
-260
-12% -$72.1K 0.08% 77
2019
Q3
$489K Buy
2,100
+10
+0.5% +$2.33K 0.08% 70
2019
Q2
$489K Buy
+2,090
New +$483K 0.1% 75

Other funds holding BIIB